RXRX
Price
$3.50
Change
+$0.16 (+4.79%)
Updated
Aug 21 closing price
Capitalization
1.89B
81 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.39
Change
+$0.07 (+2.11%)
Updated
Aug 21 closing price
Capitalization
208.88M
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXRX vs VYGR

RXRX vs VYGR Comparison Chart in %
View a ticker or compare two or three
VS
RXRX vs. VYGR commentary
Aug 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 22, 2026
Stock price -- (RXRX: $3.34 vs. VYGR: $3.32)
Brand notoriety: RXRX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 80% vs. VYGR: 85%
Market capitalization -- RXRX: $1.89B vs. VYGR: $208.88M
RXRX [@Biotechnology] is valued at $1.89B. VYGR’s [@Biotechnology] market capitalization is $208.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 7 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • RXRX’s TA Score: 7 bullish, 3 bearish.
  • VYGR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than VYGR.

Price Growth

RXRX (@Biotechnology) experienced а +0.91% price change this week, while VYGR (@Biotechnology) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 11, 2026.

VYGR is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.89B) has a higher market cap than VYGR($209M). VYGR YTD gains are higher at: -15.522 vs. RXRX (-18.337). VYGR has higher annual earnings (EBITDA): -123.44M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. VYGR (141M). VYGR has less debt than RXRX: VYGR (34.6M) vs RXRX (72.4M). RXRX has higher revenues than VYGR: RXRX (65.7M) vs VYGR (36.5M).
RXRXVYGRRXRX / VYGR
Capitalization1.89B209M906%
EBITDA-478.66M-123.44M388%
Gain YTD-18.337-15.522118%
P/E RatioN/A6.00-
Revenue65.7M36.5M180%
Total Cash654M141M464%
Total Debt72.4M34.6M209%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXVYGR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 20 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARDC12.330.02
+0.16%
Ares Dynamic Credit Allocation Fund
QQDN22.44N/A
N/A
ProShares UltraShort Top QQQ
FPX183.12-1.12
-0.61%
First Trust US Equity Opportunities ETF
BALQ55.08-0.40
-0.73%
iShares Nasdaq Premium Income Active ETF
OASC34.63-0.27
-0.77%
OneAscent Enhanced Small and Mid Cap ETF